However, long-term (five days) treatment with 5 μM olaparib downregulates p53 in the p53MUT ovarian cancer cell line OVCAR-3, whereas in the p53WT cell line A2780, it upregulates p53 expression [68]. The gene discussed is TP53; the disease is ovarian carcinoma.